The impact of affective symptoms on personal recovery of patients with severe mental illness
Van Eck, R.,
Burger, T., Schenkelaars, M.,
Vellinga, A.,
De Koning, M.B.,
Schirmbeck, F.,
Kikkert, M.J.,
Dekker, J.J.M. &
De Haan, L.Verschenen in International Journal of Social Psychiatry , Vol. 64 (6), 521-527 (2018)
Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis
Vingerhoets, C., Bloemen, O.J.N., Boot, E., Bakker, G.,
De Koning, M.B., da Silva Alves, F., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Psychiatrie Research: Neuroimaging, 272, 65-70 (2018)
Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis
Bakker, G., Caan, M.W.A., Schluter, R.S., Bloemen, O.J.N., da Silva-Alves, F.,
De Koning, M.B., Boot, E., Vingerhoets, W.A.M., Nieman, D.H.,
De Haan, L., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Psychological Medicine, 46 (11) (2016)
Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome
Bakker, G., Caan, M.W.A., Vingerhoets, W.A.M., da Silva-Alves, F.,
De Koning, M.B., Boot, E., Nieman, D.H.,
De Haan, L., Bloemen, O.J., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in PlosOne (2016)
Homesick: residential and care patterns in patients with severe mental illness
De Mooij, L.D.,
Kikkert, M.J.,
Lommerse, N.M., Theunissen, J.,
De Koning, M.B.,
De Haan, L.,
Beekman, A.T.F.,
Duurkoop, P.W.R.A. &
Dekker, J.J.M.Verschenen in BMC Psychiatry, 16, 431 (2016)
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Evers, L.J., van Amelsvoort, T.A., Bakker, J.A.,
De Koning, M.B., Drukker, M. & Curfs, L.M.
Verschenen in Psychopharmacology (Berl), 232 (18), 3319-3325 (2015)
PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome
De Koning, M.B., van Duin, E.D., Boot, E., Bloemen, O.J., Bakker, J.A., Abel, K.M. & van Amelsvoort, T.A.
Verschenen in Psychopharmacology (Berl), 232, 3111-3122 (2015)
Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis
De Koning, M.B., Bloemen, O.J.N., van Duin, E.D.A., Booij, J., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 28 (6), 553-560 (2014)
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
Bloemen, O.J.N.,
De Koning, M.B., Gleich, T., Meijer, J.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in European Neuropsychopharmacology, 23 (2), 126-132 (2013)
Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158Met polymorphism in adults with 22q11 deletion syndrome
De Koning, M.B., Boot, E., Bloemen, O.J.N., van Duin, E.D.A., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 26 (12), 1548-1560 (2012)
Hippocampal Glutamate Levels and Striatal Dopamine D2/3 Receptor Occupancy in Subjects at Ultra High Risk of Psychosis
Bloemen, O.J.N., Gleich, T.,
De Koning, M.B., da Silva Alvis, F.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Biological Psychiatry, 70 (1), e1-e2 (2011)
White-matter markers for psychosis in a prospective ultra-high-risk cohort
Bloemen, O.J.N.,
De Koning, M.B., Schmitz, N., Nieman, D.H., Becker, H.E.,
De Haan, L., Dingemans, P., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Psychological Medicine, 40 (8), 1297-1304 (2010)
Early intervention in patients at ultra high risk of psychosis: benefits and risks.
De Koning, M.B., Bloemen, O.J.N., van Amelsvoort, T.A.M.J., Becker, H.E., Nieman, D.H., van der Gaag, M. & Linszen, D.H.
Verschenen in Acta Psychiatrica Scandinavia, 119 (6), 426-442 (2009)
Challenge and therapeutic studies using alpha-methyl-para-tyrosine (AMPT) in neuropsychiatric disorders: a review
Bloemen, O.J.N.,
De Koning, M.B., Boot, E., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Central Nervous System Agents in Medicinal Chemistry, 8 (4), 249-256 (2008)
